Primary Care Physicians, Nurse Practitioners, Physician Assistants
ACCME ACCREDITATION STATEMENT
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Albert Einstein College of Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AANP ACCREDITATION STATEMENT
National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 0.25 contact hours of continuing education.
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by intense itching and recurrent eczematous lesions. The disease affects up to 20% of children and up to 3% of adults. AD usually starts in childhood, and may represent the cutaneous manifestation of an “atopic march” in which most patients also develop asthma and allergic rhinitis.
AD has a tremendous negative impact on the quality of life of both patients and their families. The disease is associated with several comorbidities, including mental health disorders (depression, anxiety, autism, ADHD), hypertension, obesity, infections, osteoporosis, fractures, vitiligo, alopecia areata, visual problems, and dental issues. Patients are more accident-prone, sleep disturbances are common, and persist even during periods of remission.
This online curriculum will examine the clinical characteristics, the current immuno-pathophysiology, and the psychosocial and quality of life impact of AD on patients across age groups, and provide strategies to individualize treatment for patients with atopic dermatitis.
This activity is supported by an educational grant from Pfizer Inc.
FACULTY DISCLOSURE POLICY
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities.
The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relationship with a commercial interest*. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.
Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
The staff of the Center for Continuing Professional Development has no relevant conflicts of interest with any ACCME-defined commercial interest.
*The ACCME defines a commercial interest as an entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by or used on patients. The ACCME does not consider providing clinical service directly to patients to be commercial interests - unless the provider of the clinical service is owned, or controlled by, an ACCME-defined commercial interest.
Brad Glick, DO has disclosed the following relevant financial relationships:
Advisor for AbbVie, Celgene, Dermavant, Dermira, Lilly, Novartis, Ortho Dermatologics, Pfizer, Sanofi Genzyme, and Sun Pharma
Investigator for AbbVie, Celgene, ChemoCentryx, Dermira, and Sun Pharma
Speakers' Bureau for AbbVie, Celgene, Dermira, Lilly, Novartis, Ortho Dermatologics, Pfizer, and Sun Pharma
Adelaide Hebert, MD has disclosed the following relevant financial relationships:
Consulting fees received from Cutanea, Demira, Galderma, Menari, Ortho, and UCB
Data and Safety Monitoring Board for Bausch, GlaxoSmithKline, and Sanofi Regeneron
Principal Investigator for Brickell, Cutanea, Demira, Pfizer, and Novan
Speakers’ Bureau for Almirall, Cutanea, Menarini, Ortho, and Pfizer
Paul Yamauchi, MD has disclosed the following relevant financial relationships:
Consulting fees received from Lilly, Regeneron, and Sanofi
Principal Investigator for AbbVie, Amgen, Botanix, Galapagos, Genentech, Glenmark, Incyte, Kiniska, Leo, Lilly, Pfizer, Regeneron, and Vanda
Speakers’ Bureau for Regeneron, Sanofi, and Pfizer
INDEPENDENT PEER REVIEWER
Ranon E. Mann, MD
Assistant Professor of Medicine (Dermatology)
Albert Einstein College of Medicine
Montefiore Medical Center
Victor B. Hatcher, PhD
Associate Dean for Continuing Professional Development
Albert Einstein College of Medicine
Director, Center for Continuing Professional Development
Montefiore Medical Center
Victor B. Hatcher, PhD has no relevant conflicts of interest with any ACCME-defined commercial interest.
COURSE FORMAT/MEDIUM: Internet Activity Enduring Material
ESTIMATED TIME TO COMPLETE THE ACTIVITY: 15 min
The opinions expressed during the educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine or the National Association for Continuing Education.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Albert Einstein College of Medicine and Montefiore Medical Center, Center for Continuing Professional Development (Einstein) protects the privacy of personal and other information regarding participants and educational collaborators. Einstein will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting to the ACCME.
Einstein maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information collected from you.
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above
For video playback, install the latest version of Flash or Quicktime.
SUPPORTED PHONES & TABLETS:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above